| Vol. 15.04 – 2 February, 2023 |
| |
|
|
| Scientists found that breast cancer cells used palmitate to synthesize acetyl-CoA in a carnitine palmitoyltransferase 1a-dependent manner. [Nature Cancer] |
| |
|
|
PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Researchers showed that hyperglycemia caused active histone modifications at the Neuregulin 1 enhancer, forming enhanceosome complexes. [Nature Communications] |
|
|
|
| The authors confirmed that tissue differentiation inducing non-protein coding RNA (TINCR) upregulated programmed death-ligand 1 expression in vivo and in vitro, and promoted the progression of breast cancer. [Cell Death & Disease] |
|
|
|
| Scientists identified a specific alternative splicing (AS) signature associated with breast tumorigenesis in vitro. They characterized the role of methyltransferase-like 3 (METTL3) in modulating breast cancer-associated AS programs. [Oncogene] |
|
|
|
| Using multiomics data analysis, investigators found that lactate was mainly derived from glycolysis in breast cancer. Single-cell transcriptome analysis found that breast cancer cells with higher malignancy have higher expression levels of glycolytic metabolic enzymes. [Cancer Immunology Immunotherapy] |
|
|
|
| To investigate the underlying tumor dynamics in TNBC, the authors performed trajectory analysis on the single-nuclei RNA-seq of chemoresistant tumor clones during neoadjuvant chemotherapy. [Iscience] |
|
|
|
| Researchers found that CENPF, which was highly expressed in TNBC, was associated with a poor prognosis in patients receiving chemotherapy. [Scientific Reports] |
|
|
|
| A total of 667 breast cancer patients were enrolled in this study. Haematoxylin and eosin staining were used to count TIN in tissues. Human breast cancer cell lines were transfected with S100A9 specific small interfering RNA. [Heliyon] |
|
|
|
| After a breast cancer in situ tumor model was established, mice were randomly distributed into different groups: model, Gubenyiliu II, Quxie, Fuzheng, and tamoxifen groups, and treated correspondingly. [Anti-Cancer Drugs] |
| |
|
|
|
| The authors summarize and review the relevant research clarify that c-MYC is a key mediator between breast cancer cells and tumor microenvironment. [Cell Communication and Signaling] |
|
|
|
| Scientists evaluate cow milk’s impact on breast carcinogenesis by linking recent epidemiological evidence and new insights into the molecular signaling of milk and its constituents in breast cancer pathogenesis. [Current Nutrition Reports] |
|
|
|
|
|
Gilead Sciences, Inc. awarded $7.6 million in grant funding to 24 US-based, community organizations through the newly created Toward Health Equity Oncology Grant™. [Gilead Sciences, Inc.] |
| |
|
|
| April 14 – 19, 2023 Orlando, Florida, United States |
|
|
|
|
|
| Imperial College London – London, England, United Kingdom |
|
|
|
| Umeå University – Umeå, Sweden |
|
|
|
| Imperial College London – London, England, United Kingdom |
|
|
|
| European Molecular Biology Laboratory – Heidelberg, Germany |
|
|
|
| IRCCS Candiolo Cancer Institute – Turin, Italy |
|
|
|
|